The Efficacy of WeChat-based Multidisciplinary Full-course Nutritional Management Program - Trial NCT06379191
Access comprehensive clinical trial information for NCT06379191 through Pure Global AI's free database. This phase not specified trial is sponsored by Peking Union Medical College Hospital and is currently Completed. The study focuses on Ovarian Cancer. Target enrollment is 78 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Peking Union Medical College Hospital
Timeline & Enrollment
N/A
Feb 01, 2023
Oct 30, 2023
Primary Outcome
patient-generated subjective global assessment (PG-SGA)
Summary
As the most malignant type of cancer in the female reproductive system, ovarian cancer (OC)
 has become the second leading cause of death among Chinese women. Chemotherapy is the main
 treatment for OC patients, and its numerous adverse effects can easily lead to malnutrition.
 It is difficult to centrally manage OC patients in the intervals between chemotherapy. The
 utility of WeChat, an effective and more cost-efficient mobile tool, in chronic disease
 management has been highlighted.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06379191
Non-Device Trial